ArticlePloS one2025
Ficus benghalensis extract mediated green synthesis of silver nanoparticles, its optimization, characterization, computational studies, and its in vitro and in vivo biological potential.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Green Synthesis of Silver Nanoparticles fromMolecules (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, Silver (Ag) nanoparticles (NPs) were synthesized via green synthesis using Ficus benghalensis root extract (FBRE), serving as a capping and stabilizing agent. The synthesized Ag NPs were characterized via complementary characterization techniques, including SEM, XRD, EDS, UV-Vis, and FT-IR. SEM analysis revealed the fabrication of spherical NPs with an average size of 41.55 nm. A plasmon resonance peak was observed at 430 nm. FBRE effectively capped and stabilized the Ag NPs, ensuring their structural integrity over time, and is confirmed via FT-IR scan. DFT calculation revealed a thermodynamically and mechanically stable system. Moreover, optoelectronic properties confirmed the metallic behavior of Ag with a major contribution from 4d orbital near the fermi level and 5s orbital contribution to the conduction band with light absorption in the visible spectrum. Biological evaluations demonstrated significant enzyme inhibition. Ag NPs inhibited urease (80.76%), α-glucosidase (80.98%), carbonic anhydrase II (89.32%), and xanthine oxidase (49.9%), outperforming FBRE. In Vivo, Ag NPs exhibited dose-dependent analgesic (83.09% writhing inhibition at 10 mg/kg, similar to diclofenac) and sedative (16.09% locomotor reduction at 10 mg/kg) effects. Molecular docking confirmed strong enzyme-ligand interactions. These findings highlight the biomedical potential of FBRE-synthesized Ag NPs, particularly for enzyme inhibition and pharmacological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.